The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial

Etienne Aliot, Axel Brandes, Lars Eckardt, Arif Elvan, Michele Gulizia, Hein Heidbuchel, Josef Kautzner, Lluis Mont, John Morgan, André Ng, Lukasz Szumowski, Sakis Themistoclakis, Isabelle C Van Gelder, Stephan Willems, Paulus Kirchhof

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

Early and comprehensive maintenance of sinus rhythm is conceptually of paramount importance to prevent cardiovascular complications related to atrial fibrillation (AF). The EAST will evaluate the effect of early and modern rhythm control interventions on the outcome of patients with AF.
Original languageEnglish
Pages (from-to)255-256
Number of pages2
JournalEuropean Heart Journal
Volume36
Issue number5
Early online date2 Feb 2015
DOIs
Publication statusPublished - Feb 2015

Keywords

  • Anti-Arrhythmia Agents
  • Atrial Fibrillation
  • Catheter Ablation
  • Humans
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Stroke

Fingerprint

Dive into the research topics of 'The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial'. Together they form a unique fingerprint.

Cite this